Tumor treating fields have demonstrated efficacy and safety, especially in glioblastoma treatment, but clinical uptake ...

The phase 1b/2 ELEVATE study evaluated everolimus, an mTORC1 inhibitor, plus elacestrant, a next-generation, oral selective ER degrader, in adult patients with ER+/HER2- breast cancer.

In this study, researchers developed and evaluated a blood-based cell-free and exosomal miRNA panel for detecting early-stage CRC and advanced adenomas.

Researchers evaluated the real-world outcomes of lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma.

In this analysis, researchers sought to assess the impact of the 21st Century Cures Act, which gave the FDA increased flexibility to accept a single pivotal trial as the basis for a novel drug ...

Phase 3 RASolute 302 data show daraxonrasib significantly extended overall and progression free survival compared with ...

(HealthDay News) — For patients with non-small cell lung cancer (NSCLC), thymic radiation exposure is independently associated with increased risks for distant metastasis, according to a study ...

Burden is highest in men and correlates with some modifiable factors like smoking, body mass index, and occupational benzene/formaldehyde exposure ...

Investigators evaluated the efficacy and safety of immune checkpoint inhibitors in high-risk patients with genitourinary cancers and advanced chronic kidney disease.

In this analysis, researchers explored patterns of surgical care and factors associated with undergoing bilateral mastectomy as primary breast surgery.

Researchers evaluated associations of county-level medical debt, a known social determinant of health, with diagnosis stage and survival among patients newly diagnosed with cancer.

Investigators characterized active surveillance use for favorable intermediate-risk prostate cancer in the US Veterans Affairs System.